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METHODS 
Case Material and Indications 
. ABSTRACT. Bet"ieen March 1963 and January 1978, 74 
patients 18years of age or younger have had liver replace-
ments at the University of Colorado Medical Center, Den-
ver. The most common cause of native liver failure was The reasons for proceeding are giveri in Table 
biliary atresia (48/74.65%); the second most common cause I. All 74 patients had chronic liver disease. Biliary 
was chronic ag"rrressive hepatitiS (12174, 16%). Twenty-hine atresia was the. most common diagl~osisI account-
patients (39%) lived for at least one year, and 16 are still alive 
f ing for almost hvice as man," cases as all other one to n!neyears a ter transplantation. Technical surgical 
problems. rejection, and infection were the main causes of diseases combined (Table I). Chronic aggressive 
death. Improved immunosuppression is needed; neverthe- hepatitis was the next most common diagnosis. 
Jess, the quality of life in the long-tenn survivors has Eight patients had inbom errors of metabolism, 
enc~l:Kraged co~tinuatiIon .of ~his difficult wo~kK Pediatrics including acantitrvpsin deficiency, \Vilson's dis-
63;820-829, 19,9, pedwtrlc, llcer, transplantatIOn, surgery. . .• • d t' 1\7 1 t 
... _. ___ ._____ . . _______ K_~asKeI tyrosmemla, an ype g ycogen s orage 
Two n1edical groups have accumulated a pre-
ponderance of the world experience in orthotopic 
liver transplantation (liver replacement), our 
own, at the UniverSity of Colorado Medical 
Center,1.2 and the Eriglish team headed by Cal~e 
and \Villiams that works at Cambridge University 
and Kings College in London.3 The British group 
has treated very few children because they rarely 
have had pediatric donors. hi. addition, they have 
been fearful of the growth limitation and cosmet-
ic deformity inherent in long-term steroid thera-
py. Consequently, most of the world experience 
with pediatric liver transplantation has been from 
the University of Colorado series. In this report, 
the results will be given for 74 pediatric recipi-
ents (18 years old or younger) who had liver 
replac:emeilt between :\larch 196.3 and January 
1978. Thus, a minimuni potential lf~e-year 
follow-up is available in every case. 
disease. It has been established that the enzyine 
specificity and protein synthetic phenotypes of 
liver homografts remain permariently those of the 
donor. 1 . 3 Thus, any liyer-based inborn error of 
metabolism is potentially curable with liver trans-
plantation. _ 
The appropriate time to recommend liver 
transplantation required judgment. The predict-
.able and tragic course of victims of biliary atresia 
usually made it easy to proceed relatively early. 
However, this situation has been made more 
ambiguous with the increasing number of patients 
with successful or partly successful portoenteros-
. tomy. In such cases, it has been a technical 
advantage to have' the potential recipient grow 
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autopsy. The most common technique then used 
was cholecvstoduodenostomv after ligation of the 
. Common d:lct. Even with s~emingly satisfactory 
biliary drainage, the patients had an extraordina-
n" incidence of bacteremia, which was probably 
(:aused by repeated contamination through the 
anastomosis between the gallbladder and duode-
num. An important component of the reforms 
instituted several years ago was constant postop-
erative suspicion of the biliary reconstruction. 
Postoperative jaundice, fever, or abdominal pain 
has become a signal for cholangiography (T-tube 
or transhepatic), reexploration, or often both. 
\Ve abandoned cholecystoduodenostomy in 
1974 and now do duct-ta-duct anastomoses over a 
T-tube if this is feasible, which it never is if the 
diagnosis is biliary atresia. Reasonable options are 
cholecystojejunostomy and choledochojejunosto-
my anastomosing the gallbladder or common duct 
into an 18-in Roux limb. "'ith cholecystojejunos-
tomy, about one third of recipients develop 
obstruction of the cystic duct, but cholecystecto-
my and conversion to choledochoenterostomy has 
proved to be easy. It lIas seemed safer to secon-
darilv anastomose such a dilated common duct to 
bow~l than to attempt this initially w,ith the tiny 
common duct of a normal infant liver. Formation 
of a Roux limb is hazardous in heavily immuno-
suppressed recipients. Eight patients in our 
combined adult-pediatric series of 141 have died 
from later perforations at the enteroenterostolny.2 
Four \vere infants or children. . 
Anomalies have been common in children with 
biliary atresia. The most serious was a combina-
tion of a pre duodenal portal vein, a hepatic artery 
originating from the superior mesenteric artery, 
absent inferior vena cava, and malrotation of the 
gut. 1 \Ve have seen this four times. \Ve considered 
such cases to be untreatable until a success was 
obtained in a child who is now four years and four 
months postoperative. Other less ominous donor 
and recipient anomalies and their technical impli-
cations are described elsewhere.1 
In many patients, splenectomy is advisable 
because of hypersplenism or massive splenomega-
ly. Failure to remove "the spleen may lead to an 
inability to give the important drug azathioprine 
in the postoperative period because of persistent 
leukopenia. 1 However, splenectomy in infants is 
knO\vn to predispose pneumococcal and other 
kinds of bacteremia. 
Postoperative Management 
There are two fundamental guidelines. The 
first is to prevent or control rejection by combi-
nation drug therapy, which is begun on the day of 
operation and continued indefinitely. The second 
is to accurately diagnose postoperative hepatic 
dysfunction. ;'\umerous technical surgical pitfalls 
were mentioned earlier. of which biliary tract 
problems were the most important and treatable. 
Besides ruling out biliary complications with 
cholangiography, frequent liver biopsies can 
strengthen the diagnosis of rejection, or they can 
point out other possibilities such as ischemic or 
drug injury and hepatitis. In short, the patient 
with postoperative hepatic malfunction should be 
approached unprejudiciaUy as a diagnostic prob-
lem rather than assuming that rejection is the 
diagnosis. 
If other factors are ruled out, the patient's. 
survival (short of retransplantation) depends upon 
control of rejection. As much azathioprine is 
given as is possible without causing bone marrow 
depression and leukopenia. The dose-rnaneuvera-
ble agent to meet crises is thus prednisone. Most 
" patients are also given a two- or three-week 
course of intravenous antilymphocyte globulin 
(ALG).l.2 Although these double- or triple-agent 
regimens usually can prevent or reverse rejection, 
the price of prolonged high-dose steroid therapy 
is all too frequently an inexorable decline of the 
patient's health, capped in "the end by a fatal 
infection. ~ . 
. RESULTS 
_. 
The outcome in 74 pediatric patients treated 
one to almost 16 years ago is given in Table 1. 
Twenty-nine (39%) of the 74 recipients lived for 
at least or.e year after operation and 16 (22%) still 
survive, all but four with follow-ups of more than 
two years. Ten of the 16 long-term survivors have 
follow-ups of at least four years, with a maximum 
of nine years. The 13 late deaths occurred from 
one to six years postoperatively (times of death 
are given in a footnote to Table I). It has been 
documented that many of the patients who died 
after one veal' were already in trouble at the 
12-month ~onvalescence ma'rk/ and. thus might 
have been saved by earlier consideration of 
retransplantation. The commonest cause of death 
after one year was chronic rejection.2 
Although the results have slowly improved 
over the years, the overall percentage of one-year 
survival of pediatric recipients from 1963 to the 
summer of 1976 was only 35%. By this time the 
technical and management improvements de-
scribed earlier had been completed. From then 
until December 1977, the one-year survival rate 
in pediatric recipients was 62%. 
Pooling the total pediatric experience from 
1963 to 1977, we found that the results in patients 
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l~~s steroids, \\'e have in the last year used 
thoracic duct drainage as a lymphoid-depleting 
immunosuppressive adjunct, usually starting on -
the day of transplantation, and continuing for one 
to three monthsK~ It is too early to judge the value 
of this procedure or to preclude the possibility 
that its greatest-effectiveness will be for pretreat-
ment of transplantation. \Vhat is clear is that the 
next major improvement in survival will depend 
on some kind of improvement on the double- and 
triple-drug programs that have been so dangerous 
in the past. 
\Vith end-stage liver disease, nothing short of 
new hepatic tissue will permit survival. Thus, the 
only alternative to liver replacement is auxiliary 
liver transplantation involving' the placement of 
an extra liver in some ectopic site, such as the 
right paravertebral gutter, pelvis, or splenic fossa. 
Fortner et al5 recentl): compiled a total of 43 
of good medical management. For these children 
the only opportunity for survival is liver trans-
plantation. At present, liver replacement is more 
successful than am.:iliary liver transplantation. In 
children with chronic survival after liver replace-
ment, the quality of life and the degree of 
rehabilitation suggest that this difficult treatment 
\vill be increasingly used, particularly if survival 
continues to improve. 
So far, liver transplants have .been perforo-jed 
only in clinical research centers, thereby shielding 
parents from hospitalization and phYSician 
expenses. The grant costs in this research setting 
have been comparable to those for renal recipi-
ents in the developmental phases of kidney trans-
plantation some years ago, allowing for an infla-
tion factor. 
SUMMARY 
clinical trials contributed from many centers, Orthotopic liver transplantation was per-·· 
including four from the University of Colorado formed on 74 pediatric patients between March 
and seven from their own institution. There had' 1963 and January 1978. The most common indi-
been only one unqualified success, that being tIle cations for operation were biliary atresia (48 
5;'2-year postoperative survival of a child with examples) and chronic aggressive hepatitis (12 
biliary atresia. In this case, the auxiliary liver was examples). Twenty-nine recipients (39%) lived for 
still functioning \vell in September 1978. All of at least one vear and 16 are alive now with 
. the other patients died within a few weeks or follO\v-ups or' one to nine years. The results 
months after the operation. The division between improved slowly for the first 13 years, and more 
pediatric and adult recipients is not clear in these rapidly since 1976, when the one-year survival 
collected cases. has been 62%. Technical surgical complications. 
~fany of the failures after auxiliary liver trans- systemic side effects of immunosuppression, and 
-plantation have resulted from the need for- -incompletely controlled rejection accounted for 
awkward or tenuous revascularization procedures most of the early, as well as the late deaths. 
and from the placement of an extra organ in an 
abdomen that may already be overcrowded. For 
ideal revascularization, blood returning from the 
splanchniC viscera should pass preferentially 
through the homograft," a condition that may be 
technically difficult to achieve. 
In tl1e future, the most important use of auxil-
iary liver transplantation may be to tide patients 
over a bout of fulminant hepatic failure, allowing 
time for the acutely damaged native liver to 
regenerate. The concept has been validated in 
controlled animal experiments and even in 
partially successful clinical trials at our institu-
tion, but long-term survival of such patients has 
not yet been accomplished. 
IMPLICATIONS 
Each year children die from liver failure due to 
uncorrectable biliary atresia, chronic aggressive 
hepatitis, or inborn errors of metabolism, in spite 
REFERENCES 
1. StaTzl TE (\\ith the assistance of Putnam CW): Experi-
ence in Hepatic Transplalltation. Philadelphia, WB 
Saunders Co, 1969. 
2. StaTzl TE, Koep LJ. Halgrimson CG, et al: Fifteen years 
of clinical liver transplantation. Gastroenterology, 
. to be published. 
3. CaIne RY, Williams R: Liver transplantation, in Ravitch 
MM (ed): Current Froblems in Surgery. Chicago, 
Year Book ~ledical Publishers Inc 16Gan):3-44. 
1979. 
4. Starzl TE, Koep LJ. Schr6ter GPJ. et al: The quality of 
life after Ih'er transplantation. Transplant Proc 
11:252, 1979. . 
5. Fortner JG, Yeh SDJ, Kim DK, et al: The case for and 
technique of heterotopiC Ih'er grafting. Trall..sp7ant 
Proc 11::269,1979. .. -
6. Starzl TE, Terblanche J: Hepatotrophic substances, in 
Popper H, Schaffner F (eels): Progress ill Lir:er 
Diseases. Xc\\" York, Gnme &. Stratton, 19i9. vol 6, 
pp 13,5-152. 
ARTICLES 829 
I, 
I' 
,I 
,I 
II 
I' 
! 
, . 
, 
, . 
; 
! : 
